This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. NAD(P)H:quinone oxidoreductase (NQO1) is an important enzyme for activation of a class of antitumor agents known as bioreductive antitumor quinones. NQO1 is highly expressed in solid tumors, and reports suggest that antitumor quinones that are bioactivated NQO1 may be selectively toxic to NQO1-expressing tumor cells. We have recently discovered that analogues of lavendamycin, a complex, natural quinone from Streptomyces lavendulae, that are good substrates for NQO1 are selectively toxic to cancer cell lines with elevated NQO1 levels compared to isogenic cells without NQO1. This finding prompted us to reexamine the minimum structural elements necessary for both substrate efficiency and antitumor activity with the objective of producing simpler compounds with optimal properties such as solubility and membrane permeability. A synthetic approach for production of novel quinolinequinones has been developed, and a plan for biological testing that includes both efficacy and safety assessment is described. Spectrophotometric and HPLC assays using recombinant human NQO1 will be used to measure rates of quinone reduction. Human BE colon carcinoma cell lines with and without NQO1 will be used to test NQO1-dependent toxicity, and primary human endothelial and bone marrow mononuclear cells will be used to assess safety potential. The overall goal of this project is to produce patentable agents with potential as clinically useful antitumor drugs.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR017670-09
Application #
8167599
Study Section
Special Emphasis Panel (ZRR1-RI-5 (01))
Project Start
2010-06-01
Project End
2011-05-31
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
9
Fiscal Year
2010
Total Cost
$16,628
Indirect Cost
Name
University of Montana
Department
Other Health Professions
Type
Schools of Pharmacy
DUNS #
010379790
City
Missoula
State
MT
Country
United States
Zip Code
59812
Peters, Bridget; Ballmann, Christopher; Quindry, Tiffany et al. (2018) Experimental Woodsmoke Exposure During Exercise and Blood Oxidative Stress. J Occup Environ Med 60:1073-1081
Ward, Tony J; Semmens, Erin O; Weiler, Emily et al. (2017) Efficacy of interventions targeting household air pollution from residential wood stoves. J Expo Sci Environ Epidemiol 27:64-71
Biswas, Rupa; Trout, Kevin L; Jessop, Forrest et al. (2017) Imipramine blocks acute silicosis in a mouse model. Part Fibre Toxicol 14:36
Sanchez-Contreras, Monica; Cardozo-Pelaez, Fernando (2017) Age-related length variability of polymorphic CAG repeats. DNA Repair (Amst) 49:26-32
Ferguson, Matthew D; Semmens, Erin O; Weiler, Emily et al. (2017) Lung function measures following simulated wildland firefighter exposures. J Occup Environ Hyg 14:739-748
Park, Sunyoung; Nevin, Andrew B C; Cardozo-Pelaez, Fernando et al. (2016) Pb exposure prolongs the time period for postnatal transient uptake of 5-HT by murine LSO neurons. Neurotoxicology 57:258-269
Jessop, Forrest; Hamilton, Raymond F; Rhoderick, Joseph F et al. (2016) Autophagy deficiency in macrophages enhances NLRP3 inflammasome activity and chronic lung disease following silica exposure. Toxicol Appl Pharmacol 309:101-10
Gábriel, Robert; Erdélyi, Ferenc; Szabó, Gábor et al. (2016) Ectopic transgene expression in the retina of four transgenic mouse lines. Brain Struct Funct 221:3729-41
Wang, Xiaobo; Olson, Jenessa R; Rasoloson, Dominique et al. (2016) Dynein light chain DLC-1 promotes localization and function of the PUF protein FBF-2 in germline progenitor cells. Development 143:4643-4653
Yi, Feng; DeCan, Evan; Stoll, Kurt et al. (2015) Muscarinic excitation of parvalbumin-positive interneurons contributes to the severity of pilocarpine-induced seizures. Epilepsia 56:297-309

Showing the most recent 10 out of 161 publications